Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKPyV-specific T-cell guided immunosuppression steering after kidney transplantation
2024-517219-56-00Phase 4Authorised
- Sponsor
- Profil
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus, cyclosporine, mycophenolate mofetil, mycophenolic acid, everolimus and 4 more in BK polyomavirus infection (2 arms), sponsored by Profil. Primary endpoint: Time from randomization to end of BKPyV-DNAemia. Planned start Apr 2025; status: authorised.
02
Drugs
tacrolimuscyclosporinemycophenolate mofetilmycophenolic acideverolimus
03
Conditions
BK polyomavirus infection
Beyond the preview
Go deeper on 2024-517219-56-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517219-56-00.